GenoLogics Releases Clarity LIMS X as Part of Illumina SeqLab
REDWOOD CITY, Calif. GenoLogics today announced the availability of Clarity LIMS X, an edition of its industry-leading laboratory informatics platform. Optimized for use with Illumina® SeqLab, the X...
View ArticleGenoLogics发布 可与Illumina SeqLab搭配使用的Clarity LIMS X
加州雷德伍德城 (美国商业资讯)–GenoLogics今天宣布上市Clarity LIMS X,这是该公司业界领先的实验室信息学平台的一个版本。Clarity LIMS X版面向与Illumina® SeqLab的协同应用进行了优化,可提供群体级基因组学工作流程中的阳性样本追踪、最大化品质和处理能力、缩短处理时间。 2014年上市的HiSeq...
View ArticlePromega 2015 Corporate Responsibility Report Details Long-Term Investment for...
MADISON, Wis. The recently released Promega 2015 Corporate Responsibility Report highlights investment in the future, environmental preservation and contribution to the community. The report...
View ArticleジェノロジックスがIllumina SeqLabの一部としてClarity LIMS Xをリリース
米カリフォルニア州レッドウッドシティ (ビジネスワイヤ)– ジェノロジックスは本日、Clarity LIMS Xの提供を開始したと発表しました。Clarity LIMS Xは、業界有数の当社ラボインフォマティクスプラットフォームの1エディションです。Clarity LIMSのXエディションはIllumina®...
View Article2015 International Symposium on Human Identification (ISHI) Welcomes 50+...
MADISON, Wis. Join more than 50 experts at the world’s largest conference on DNA analysis for human identification, featuring historic keynote speaker Kirk Bloodsworth, the first person to be...
View ArticleGenomiCare Partners with N-of-One to Provide High-quality Clinical...
LEXINGTON, Mass. & SHANGHAI N-of-One, Inc., the global leader in clinical interpretation for precision medicine in oncology, and GenomiCare Biotechnology, a fast-growing precision medicine...
View ArticleExtension Study Data Supporting Long-Term Safety and Efficacy of Eloctate®...
CAMBRIDGE, Mass. & STOCKHOLM Newly published clinical data demonstrate that people on extended-interval prophylaxis regimens with ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion...
View ArticleMacrogen Launches Special Promotion on Exome Sequencing
SEOUL, South Korea The precision medicine biotech company Macrogen (CEO Chong Hyon-yong, www.macrogen.com) (KOSDAQ:038290), announced on August 10th that it is launching a special promotion on exome...
View ArticleBurning Rock and Illumina Collaborate on Molecular Diagnostics for Oncology
GUANGZHOU, China & SAN DIEGO Burning Rock and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement whereby Burning Rock will develop advanced clinical applications...
View ArticleTransgenomic Adds Asia Distributors for Its ICEme™ Kits That Enable Liquid...
OMAHA, Neb. Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced the...
View ArticleUS FDA Approves Initiation of ViroMed’s VM202 for Phase III Clinical Study of...
ATLANTA ViroMed Co., Ltd. (084990:KS, KOSDAQ) today announced that the company has received an approval from the US FDA to launch a pivotal Phase III clinical trial utilizing VM202, a proprietary...
View ArticleSamples Sought for Caldera Health “Pee in a Pot” Prostate Test
AUCKLAND, New Zealand Men with suspected prostate cancer are being urged to help Caldera Health perfect its urine diagnostic test. Molecular diagnostic firm Caldera Health is in the final stages of...
View ArticleGencia and Takeda Team to Discover and Develop Novel Class of Mitochondrial...
CHARLOTTESVILLE, Va. & OSAKA, Japan Gencia LLC and Takeda Pharmaceutical Company Limited announced today a partnership to develop a new class of small molecule drugs as potential treatments for...
View ArticleThe World Egg Bank Now Offers the Most Advanced Genetic Testing Available in...
PHOENIX The World Egg Bank Inc. has announced the first testing of banked egg donors and recipients to reduce the incidence of having a child with a genetic disease. The World Egg Bank has partnered...
View ArticleTechnavio Reports the Demand for Contactless Biometrics Will Enhance the...
LONDON Technavio has published a new report on the biometric market in BRIC countries, which is expected to grow at a CAGR of over 23% from 2015-2019. About the Report The latest report by Technavio...
View ArticleMitobridge Announces Sponsored Research Agreement to Evaluate PPARδ Compounds...
CAMBRIDGE, Mass. Mitobridge, Inc., a biopharmaceutical company pioneering the discovery and development of products that improve mitochondrial function, announces the signing of a sponsored research...
View ArticleTransgenomic Announces First License for Commercial Rights to Its Liquid...
OMAHA, Neb. Transgenomic, Inc. (NASDAQ: TBIO), today announced that it has granted a license to the University of Melbourne to use its Multiplexed ICE COLD-PCR™ (MX-ICP) technology for a number of...
View ArticleGreen Super Rice Project Funded by the Chinese Government and the Bill &...
SANTA CLARA, Calif. Affymetrix, Inc. (NASDAQ:AFFX) announced today that it has been selected as the genotyping supplier by the Green Super Rice project coordinated by the Chinese Academy of...
View ArticleCynvenio Biosystems and ATGen Announce Strategic Partnership to Bring NK Vue...
LOS ANGELES & SEOUL, South Korea Cynvenio Biosystems, Inc., a diagnostics company dedicated to enabling the new era of individualized medicine for all cancer patients, and ATGen Global, a...
View Article50+ Forensic DNA Experts to Present at the 2015 International Symposium on...
MADISON, Wis. Learn from forensic luminaries, who will share their experiences solving crimes, deciphering historical mysteries and advancing the fields of forensics and DNA analysis, at the...
View Article